BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10616282)

  • 1. Modeling the low-LET dose-response of BCR-ABL formation: predicting stem cell numbers from A-bomb data.
    Radivoyevitch T; Hoel DG
    Math Biosci; 1999; 162(1-2):85-101. PubMed ID: 10616282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically based risk estimation for radiation-induced CML. Inferences from BCR and ABL geometric distributions.
    Radivoyevitch T; Kozubek S; Sachs RK
    Radiat Environ Biophys; 2001 Mar; 40(1):1-9. PubMed ID: 11357705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene rearrangement and radiation carcinogenesis].
    Akiyama M
    Rinsho Ketsueki; 1994 May; 35(5):454-60. PubMed ID: 8028192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically-based risk estimation for radiation-induced chronic myeloid leukemia.
    Radivoyevitch T; Hoel DG
    Radiat Environ Biophys; 2000 Sep; 39(3):153-9. PubMed ID: 11095145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the primary event in radiation-induced chronic myelogenous leukemia the induction of the t(9;22) translocation?
    Holmberg M
    Leuk Res; 1992; 16(4):333-6. PubMed ID: 1564937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia patient-derived lymphoblastoid cell lines exhibit increased induction of leukemia-associated transcripts following high-dose irradiation.
    Spencer A; Granter N
    Exp Hematol; 1999 Sep; 27(9):1397-401. PubMed ID: 10480430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of chronic myeloid leukemia: can the dose-response curve be U-shaped?
    Radivoyevitch T; Kozubek S; Sachs RK
    Radiat Res; 2002 Jan; 157(1):106-9. PubMed ID: 11754648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in laboratory medicine in chronic myeloid leukemia].
    Miura A
    Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of BCR/ABL Fusion Gene by Hematological and Cytogenetical Analysis in Chronic Myeloid Leukemia Patients in Quetta, Pakistan.
    Tahira B; Asif M; Khan S; Hussain A; Shahwani MN; Malik A; Inayatullah S; Iqbal Z; Rasool M
    Asian Pac J Cancer Prev; 2015; 16(9):3793-7. PubMed ID: 25987039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular biology of chronic myeloid leukemia].
    Hellmann A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
    Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
    Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 16. Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov model.
    Radivoyevitch T; Hoel DG; Chen AM; Sachs RK
    Radiat Res; 1998 Jan; 149(1):59-67. PubMed ID: 9421155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature.
    Keung YK; Beaty M; Steward W; Jackle B; Pettnati M
    Cancer Genet Cytogenet; 2002 Oct; 138(2):139-42. PubMed ID: 12505259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9;22 translocation and bcr rearrangements in chronic myelocytic leukemia patients among atomic bomb survivors.
    Tanaka K; Takechi M; Hong J; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Dohy H; Kyo T
    J Radiat Res; 1989 Dec; 30(4):352-8. PubMed ID: 2614751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome.
    Mohamed AN; Koppitch F; Varterasian M; Karanes C; Yao KL; Sarkar FH
    Genes Chromosomes Cancer; 1995 Jun; 13(2):133-7. PubMed ID: 7542908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.